Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...

Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners' clinical development, recently presented its Next-Generation LNP advancements, a ...

The financial markets responded immediately, with BioNTech shares declining as much as 5% in pre-market trading. This partnership has historically formed the cornerstone of BioNTech's commercial ...

Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...

You are reading the Morning Briefing newsletter. Get the news that prepares you for the day ahead, delivered to your inbox.